道氏技術(300409.SZ):擬與蕪湖經開區簽訂“年產10萬噸三元前驅體項目”投資合作合同
格隆匯3月9日丨道氏技術(300409.SZ)公佈,2022年3月9日,公司召開第五屆董事會2022年第4次會議和第五屆監事會2022年第3次會議,審議通過了《關於與蕪湖經濟技術開發區管委會簽訂項目投資合同的議案》,同意公司與蕪湖經濟技術開發區管理委員會簽訂本次“年產10萬噸三元前驅體項目”投資合作合同。
項目規劃總投資約100億元,分為兩期投資,第一期投資50億元,其中固定資產投資25億元;第二期將在條件達成後分步實施。一期項目固定資產投資的資金主要來自於蕪湖戰略投資者對子公司蕪湖佳納能源科技有限公司(以下簡稱“蕪湖佳納”)的增資款,其他投資款公司擬通過金融機構貸款等方式解決。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.